IBRX
IBRX
US45256X1037
ImmunityBio, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 113.288.000 14.745.000
668.3%
Cost of Revenue 753.000 --
--
Gross Profit 112.535.000 14.745.000
663.2%
368.562.000 358.927.000
2.7%
Operating Income -256.027.000 -344.182.000
25.6%
Pretax Income -351.607.000 -413.645.000
15.0%
Net Income Common Stockholders -351.398.000 -413.564.000
15.0%
-- --
--
-- --
--
ende